Biotech

All Articles

Basilea scores $268M BARDA funding for antifungals, anti-biotics

.Basilea Pharmaceutica's work developing brand new antifungals has actually acquired a significant i...

Capricor markets Europe liberties to late-stage DMD treatment for $35M

.Having already gathered up the U.S. liberties to Capricor Therapies' late-stage Duchenne muscle dys...

FDA fragments adcomm for Applied's uncommon illness medicine

.After pushing back the choice date for Applied Therapies' metabolic problem medication govorestat, ...

Novo inks $600M NanoVation offer to research hereditary medicines ex-liver

.Novo Nordisk is actually continuing its own push in to hereditary medicines, accepting compensate N...

Innovent web links cytokine to colorectal cancer reactions

.Innovent Biologics has actually created the scenario that its own checkpoint inhibitor-cytokine com...

Merck, Daiichi ADC hits target in period 3 bronchi cancer research study

.A stage 3 test of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) h...

Rakovina deepens AI focus along with collab to decide on cancer aim ats

.Five months after Rakovina Therapeutics rotated towards artificial intelligence, the cancer-focused...

Ascendis' dwarfism drug hits in period 3, intimidates BioMarin

.Ascendis Pharma has actually emerged as a potential danger to BioMarin's Voxzogo, stating phase 3 d...

Despite ph. 3 overlook, Alkeus views pathway ahead for eye health condition possession

.Though Alkeus Pharmaceuticals' oral eye ailment possession neglected to substantially decrease geog...

Kairos goes social along with $6M IPO to finance tests of cancer cells drug

.With a trio of biotechs hitting the Nasdaq on Friday, it was actually quick and easy to skip a smal...